The information in this section is intended for visitors outside the United States.
Gilead Sciences Announces Fourth Quarter 2017 Dividend
Print |
Gilead Sciences Announces Third Quarter 2017 Financial Results
Print | PDF
Kite Pharma to Present at the Citi 9th Annual Biotech Conference on Wednesday, September 3
Gilead Sciences to Present at the Credit Suisse 26th Annual Healthcare Conference on Tuesday, November 7
Gilead Announces Phase 2 Results for GS-0976 in Nonalcoholic Steatohepatitis (NASH)
Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®
grants@gilead.com
Phone: 650-522-1696
Fax: 650-522-1707
@GileadSciences
2014 Corporate Contributions Report
2015 Annual Review